CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer. - Yuqi Sheng; Ying Jiang; Yang Yang 009; Xiangmei Li; Jiayue Qiu; Jiashuo Wu; Liang Cheng 006; Junwei Han (Briefings Bioinform., 2021)

A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy. - Xiangmei Li; Yalan He; Jiashuo Wu; Jiayue Qiu; Ji Li; Qian Wang; Ying Jiang; Junwei Han (Briefings Bioinform., 2022)

DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network. - Jiashuo Wu; Xiangmei Li; Qian Wang; Junwei Han (Bioinform., 2022)

iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network. - Yuqi Sheng; Jiashuo Wu; Xiangmei Li; Jiayue Qiu; Ji Li; Qinyu Ge; Liang Cheng 006; Junwei Han (Briefings Bioinform., 2023)

DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19. - Yinchun Su; Jiashuo Wu; Xiangmei Li; Ji Li; Xilong Zhao; Bingyue Pan; Junling Huang; Qingfei Kong; Junwei Han (Comput. Biol. Medicine, 2023)

IDMIR: identification of dysregulated miRNAs associated with disease based on a miRNA-miRNA interaction network constructed through gene expression data. - Jiashuo Wu; Xilong Zhao; Yalan He; Bingyue Pan; Jiyin Lai; Miao Ji; Siyuan Li; Junling Huang; Junwei Han (Briefings Bioinform., 2024)

Knowledge-Based Artificial Intelligence System for Drug Prioritization. - Yinchun Su; Jiashuo Wu; Xilong Zhao; Yue Hao 008; Ziyi Wang; Yongbao Zhang; Yujie Tang; Bingyue Pan; Guangyou Wang; Qingfei Kong; Junwei Han (J. Chem. Inf. Model., 2025)